º´¸®ÇÐÀû T0 º´±â Àü¸³¼±¾ÏÀÇ º´¸®ÇÐÀû Ư¼º°ú ¿¹ÈÄ
Pathologic Characteristics and Prognosis of Pathologic T0 Prostate Cancer
À̽·Ä, ÇÔ¿ø½Ä, ±è¿øÅÂ, ÁÖÈñÁ¤, ÀÌÁø¼±, ÃÖ¿µµæ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ½Â·Ä ( Lee Seung-Ryeol )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÇÔ¿ø½Ä ( Ham Won-Sik )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±è¿øÅ ( Kim Won-Tae )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÁÖÈñÁ¤ ( Ju Hee-Jeong )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÀÌÁø¼± ( Lee Jin-Sun )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÃÖ¿µµæ ( Choi Young-Deuk )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358320090500030229
Abstract
Purpose: We evaluated the pathologic characteristics and prognosis of pathologic T0 (pT0) prostate cancer (PC).
Materials and Methods: Of 1,196 consecutive men who underwent radical prostatectomy (RP) between January 1992 and November 2008, 34 patients (mean age, 68.8¡¾7.9 years; range, 48-85) had pT0 PC. They were categorized into 4 groups according to neoadjuvant hormone therapy (NHT) and diagnostic methods. The initial PSA, 5 alpha-reductase inhibitor (5¥áRI), Gleason score of prostatic needle biopsy (PNB) or transurethral resection of the prostate (TURP), clinical stage, and presence of high-grade prostatic intraepithelial neoplasia were evaluated. Clinical and biochemical progression were also evaluated.
Results: 34 patients were categorized into 4 groups (Group I: 9 without NHT, diagnosed by PNB [1.1%]; Group II: 8 without NHT, diagnosed by TURP [11.3%]; Group III: 16 with NHT, diagnosed by PNB [5.5%]; Group IV: 1 with NHT, diagnosed by TURP [3.8%]). Group I had serum prostate-specific antigen (PSA)£¼15.0 ng/ml, one positive biopsy core, and a Gleason score¡Â7. Group II had serum PSA£¼10.1 ng/ml, chips involved with cancer£¼10.0%, and a Gleason score¡Â6. There were more patients taking 5¥áRI and high-grade PIN among patients without NHT. None of patients with pathologic pT0 PC had clinical or biochemical progression during follow-up, except 3 patients with NHT (mean, 22 months; range,
2-105 months).
Conclusions: Patients without NHT had more favorable clinical and pathologic results. In our study, except for 3 patients with NHT, all patients had undetectable PSA levels after RP. We need more time for follow-up to conclude whether the prognosis of pT0 PC is favorable.
Å°¿öµå
Prostatic neoplasms;Prostatectomy
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸